| Date | Form | Description | Docs | XBRL | Pages |
| 09/16/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/15/22 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 09/14/22 | UPLOAD | SEC-generated letter |
|
1 | |
| 09/12/22 | DEL AM | Separately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statement |
|
1 | |
| 09/09/22 | S-3 | Registration statement for specified transactions by certain issuers |
|
68 | |
| 09/09/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
21 |
| 08/17/22 | 8-K | Current report filing |
|
|
2 |
| 06/28/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/10/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
19 |
| 05/02/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Read More...Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Read More...Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Read More...